Optimization of Pothomorphe umbellata (L.) Miquel topical formulations using experimental design

International Journal of Pharmaceutics

Volumn 353, Issue 1-2, 2008, Pages 149-159

  Noriega, Peky ^a   Ropke, Cristina D ^a   Consiglieri, Vladi O ^a   Taqueda, Maria E S ^a   Tavares, Leoberto C ^a   Wasicky, André ^a   Bacchi, Elfriede M ^a   Barros, Silvia B M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

4 Nerolidylchatecol; Experimental design; Formulation optimization; Pothomorphe umbellata; Skin permeation; Ternary plots

Indexed keywords

4 NEROLIDYLCHATECOL; ANTIOXIDANT; PLANT EXTRACT; POTHOMORPHE UMBELLATA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAZIL; CENTRIFUGATION; COMPUTER GRAPHICS; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; EMULSION; INCIDENCE; MATHEMATICAL MODEL; MEDICINAL PLANT; MOLECULAR STABILITY; MOUSE; NONHUMAN; PHOTOAGING; POTHOMORPHE UMBELLATA; PRIORITY JOURNAL; SKIN DEFECT; SKIN PERMEABILITY; STATISTICAL MODEL; ULTRAVIOLET B RADIATION;

EID: 40149095069     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.11.039     Document Type: Article

References (38)

1. S. Akhnazarova V. Kafarov Experiment Optimization in Chemistry and Chemical Engineering 1982 Mir Publisher Moscow
2. A. Armstrong K. James Pharmaceutical Experimental Design and Interpretation 1996 Taylor & Francis London pp. 205–223
3. A. Arvouet-Grand B. Vennat B. Lejeune A. Pourrat Formulation of propolis extracts emulsions. I. O/W creams based on non-ionic surfactans and various consistency agents Drug Dev. Ind. Pharm. 21 1995 1907 1915
4. N.B. Barros I. Scarminio R. Bruns Planejamento e Otimização de Experimentos 1996 UNICAMP Campinas
5. S. Barros C.D. Ropke T.C.H. Sawada V.V. Silva S.M.M. Pereira M.B.S. Barros Assessment of acute and subchronic oral toxicity of extract of Pothomorphe umbellata L. Miq. (Pariparoba) Braz. J. Pharm. Sci. 41 2005 53 61
6. N. Bohidar K. Peace Pharmaceutical formulation development K. Peace Biopharmaceutical Statistic for Drug Development 1988 Marcel Dekker New York
7. S. Bolton Pharmaceutical Statistics. Practical and Clinical Applications 1991 Marcel Dekker New York pp. 421–452
8. C.M. Chiang G.L. Flynn N.D. Weiner G.J. Szpunar Bioavailability assessment of topical delivery systems: effect of inter-subject variability on relative in vitro deliveries of minoxidil and hydrocortisone from solution and ointment formulations Int. J. Pharm. 50 1989 21 26
9. J.A. Cornell Experiments with Mixtures: Designs, Models and the Analysis of Mixture Data 1990 Wiley New York
10. L. Eriksson E. Johansson C. Wikstrom Mixture design: design generation, PLS analysis, and model usage Chemomet. Intell. Lab. Syst. 43 1998 1 24
11. Freitas, P.C.D., 1999. Atividade antioxidante de espécies medicinais da família Piperaceae: Pothomorphe umbellata (L.) Miq. e Piper regnellii (Miq.) C. DC. Ph.D. Thesis. São Paulo University, Brazil.
12. M.J. Fresno M.M. Jimenez E. Sellés Galenic and dermopharmaceutical effectiveness study of an emusifield pharmaceutical form with retinoic acid Drug Dev. Ind. Pharm. 24 1999 73 79
13. K.R. Gustafson Cardelina FJ.H. II. J.B. Mcahon L.H. Pannell G.M. Cragg M.R. Boyd The peltatols, novel HIV-inhibitory cathecol derivatives from Pothomorphe peltata J. Org. Chem. 57 1992 2809 2811
14. L.A. Hir Noções de Farmácia Galênica sixth ed. 1997 Organização Andrei Editora São Paulo
15. T. Isobe A. Ohsaki K. Nagata Antibacterial constituents against Helicobacter pylori of brazilian medicinal plant, Pariparoba Yakugaku Zasshi 122 2002 291 294
16. A. Kijjoa A.M. Giesbrecht M.K. Akisue O.R. Gottlieb H.E. Gottlieb Nerolidylcatechol from Potomorphe umbellata J. Med. Plant Res. 39 1980 85 87
17. G. Marti-Mestres F. Nielloud R. Marti H. Maillois Optimization with experimental design of nonionic, anionic, and amphoteric surfactants in a mixed system Drug Dev. Ind. Pharm. 23 1997 993 998
18. T. Martinello T.M. Kaneko M.V.R. Velasco M.E.S. Taqueda V.O. Consiglieri Optimization of poorly compactable drug tablets using the mixture experimental design Int. J. Pharm. 322 2006 87 95
19. M. Moraes S. Akisue M.B. Oliveira F.G. Akisue Chromatographic characterization of crude drug and fluid extract of Pothomorphe umbellata (L.) Miq. Farm. Química 24 1984 1 9
20. P. Noriega C.D. Ropke C.M. Camilo P.C.D. Freitas S.B.M. Barros Evaluation of extraction conditions of 4-nerolydylchatecol from Pothomorphe umbellata (L.) Miq. using factorial design Braz. J. Pharm. Sci. 41 2005 261 269
21. D.W. Osborne The use of phase behavior and laboratory robotics for the optimization of pharmaceutical topical formulations D.W. Osborne A.H. Amann Topical Drug Delivery Formulations 1990 Marcel Dekker New York 143 195
22. I.C. Paula G.G. Ortega V.L. Bassani P.R. Petrovick Development of ointment formulations prepared with Achyrocline satureioides spray-dried extracts Drug Dev. Ind. Pharm. 24 1998 235 241
23. W. Peckolt Contribuição à matéria médica vegetal do Brasil: estudo farmacognóstico de Heckeria umbellata (L.) Kunth. Mem. Inst. Butantan 15 1941 59 68
24. 3 factorial design AAPS PharmaScienTech 4 2003 1 9
25. K.R. Rezende S.B.M. Barros Quantification of 4-nerolydylchatecol of Pothomorphe umbellata (Piperaceae) in rat plasma samples by HPLC UV Braz. J. Pharm. Sci. 40 2004 373 380
26. O.O. Riedel Subsídios para o estudo farmacognóstico da Heckeria umbellata (Linné) Kunth. Trib. Farm. 9 1941 269 283
27. C.D. Ropke T.M. Kaneko R.M. Rodrigues V.V. Silva S. Barros T.C.H. Sawada J.M. Kato S.B.M. Barros Evaluation of percutaneous permeation of 4-nerolidylcatechol for four topical formulations Int. J. Pharm. 249 2002 109 116
28. C.D. Ropke R.M. Rodrigues V.V. Silva S. Barros T.C.H. Sawada S.B.M. Barros Pothomorphe umbellata extract prevents α-tocopherol from depletion after UV-irradiation Photochem. Photobiol. 78 2003 109 116
29. C.D. Ropke E.A. Ostrosky T.M. Kaneko C.M. Camilo T.C.H. Sawada S.B.M. Barros Validação de metodologias analíticas para determinação quantitativa de α-tocoferol e 4-nerolidilcatecol Braz. J. Pharm. Sci. 39 2003 209 217
30. C.D. Ropke T.C.H. Sawada V.V. Silva N.S. Michalany S.B.M. Barros Photoprotective effect of Pothomorphe umbellata root extract against ultraviolet radiation induced chronic skin damage in the hairless mouse Clin. Exp. Dermatol. 30 2005 272 276
31. C.D. Ropke V.V. Silva C.Z. Kera D.V. Miranda R.L. Almeida T.C.H. Sawada S.B.M. Barros In vitro and in vivo inhibition of skin matrix metalloproteinases by Pothomorphe umbellata root extract Photochem. Photobiol. 82 2006 439 442
32. S.R. Schmidt R.G. Launsby Understanding Industrial Designed Experiments fourth ed. 1998 Air Academy Press Colorado Springs pp. 29–30
33. V.P. Shah C.R. Behl G.L. Flynn W.I. Higucchi H. Schaefer Principles and criteria in the development and optimization of topical therapeutic products Int. J. Pharm. 82 1992 21 28
34. R.A.D. Silva Farmacopéia dos Estados Unidos do Brasil first ed. 1926 Nacional São Paulo p. 649
35. V.V. Silva C.D. Ropke R.L. Almeida D.V. Miranda C.Z. Kera D.P. Rivelli T.C.H. Sawada S.B.M. Barros Chemical stability and SPF determination of Pothomorphe umbellata extract gel and photostability of 4-nerolidylcathecol Int. J. Pharm. 303 2005 125 131
36. B. Singh S.K. Chakkal N. Ahuja Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology AAPS Pharm. Sci. Technol. 7 2006 E1 E10
37. US Pharmacopeia XXVIII, 2005. US Pharmacopeial Convention, Rockville, MD, pp. 2345–2353.
38. B. Vennat A.A. Grand A. Pourrat Skin healing preparations: compared in vitro diffusion of the active ingredients Drug Dev. Ind. Pharm. 24 1998 253 260